MedPath

Safe & Easy Environment at Home for Patients Presenting a Frail Syndrome

Not Applicable
Completed
Conditions
Cognitive Deterioration
Interventions
Other: Patient's answer without non pharmacological therapeutic
Other: Patient's answer with non pharmacological therapeutic
Registration Number
NCT02288221
Lead Sponsor
Centre Hospitalier Universitaire de Nice
Brief Summary

All over the world the increasing prevalence of chronic disorders and its impact on functional decline is challenging the sustainability of health care systems. Older individuals also frequently experience the reversible "frailty syndrome", which overlaps with chronic diseases, increasing incidence of disability.

Building a global system aiming to take in charge all causes leading to loss of autonomy is a rather complicated task involving numerous Information and Communication technologies (ICT) solutions which are not always easy to use in everyday life.

The SafEE (Safe Easy Environment) project aim is to improve the safety, autonomy and quality of life of older people at risk.

The SafEE project develop non pharmacological therapeutic through diferent ICT (stimulation aromatherapy automatic fragrance, training interface based on Kinect sensor...) .

The goal of this study is to validate the acceptability, sensitivity and efficacy of the systems.

Detailed Description

The non pharmacological therapeutic will be install at patient's home :

* aromatherapy,

* music therapy,

* cognitive training in multimedia application offering cognitive games.

Also smart phone will be given to the patient :

* to help him move with a geolocation application,

* to remind him of his daily needs (shopping lists, people to call, etc ...) with an alert apllication.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
4
Inclusion Criteria
  • Male or female age ≥ 60 years with memory complaint
  • Score at the Mini Mental Test (MMSE) ≥ 26.
  • Score at the Clinical Dementia Rating Scale (CDR) ≤ 0.5.
Exclusion Criteria
  • Sensory defect (visual or olfactory) preventing the patient to perfectly meet therapeutic solutions.
  • Prescription new psychotropic medication (hypnotic, anxiolytic, antidepressant, antipsychotic) in the week preceding the assessment.
  • Subject epileptic.
  • Subject vulnerable

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Without non pharmacological therapeuticPatient's answer without non pharmacological therapeuticNo change at patient's home
With non pharmacological therapeuticPatient's answer with non pharmacological therapeuticInstallation of ICT at patient's home
Primary Outcome Measures
NameTimeMethod
Time spent by the patient using the non-therapeutic solutions6 months
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Institut Claude Pompidou

🇫🇷

Nice, France

© Copyright 2025. All Rights Reserved by MedPath